Sejal Dave
Expertise in
11
conditions

Dr. Sejal Dave

Hematology Oncology | Hematology | Oncology
500 Lauchwood Dr, 
Laurinburg, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
11
conditions
500 Lauchwood Dr, 
Laurinburg, NC 

Overview

Sejal Dave is a Hematologist Oncology specialist and a Hematologist practicing medicine in Laurinburg, North Carolina.

Dr. Dave is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, and Childhood Iron Deficiency Anemia.

Dr. Dave is board certified in American Board Of Internal Med, Hematology and American Board Of Internal Med, Medical Oncology. She is actively involved in clinical research, participating in 5 clinical trials. Dr. Dave is currently accepting new patients.

Specialties

Hematology Oncology
Hematology
Oncology

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Med, Hematology
American Board Of Internal Med, Medical Oncology

Fellowships

Hematology / Oncology, Wayne State University (Michigan)

Hospital Affiliations

Scotland Memorial Hospital
Firsthealth Moore Regional Hospital

Languages Spoken

English
Arabic
Hebrew
Hindi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Regence
  • EPO
  • PPO
Sanford Health
  • HMO
  • PPO
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Scotland Cancer Treatment Center (Duke Cancer Network)
500 Lauchwood Dr, Laurinburg, NC 28352

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug, Procedure, Radiation, Other
Study Drug: Olaparib
Study Phase: Phase 2
A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Other, Drug
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Enrollment Status: Active_not_recruiting
Publish Date: March 03, 2026
Intervention Type: Other, Dietary supplement, Drug
Study Drugs: Bevacizumab, Oxaliplatin, Leucovorin calcium, Fluorouracil, Irinotecan hydrochloride, Irinotecan
Study Phase: Phase 3
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Enrollment Status: Terminated
Publish Date: January 29, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
35
conditions
Dr. Jose A. Ruiz-Bonilla
Hematology Oncology | Hematology | Oncology
Expertise in
35
conditions
Dr. Jose A. Ruiz-Bonilla
Hematology Oncology | Hematology | Oncology
Referral may be required

Health Pavilion North Primary Care

6387 Ramsey Street, 
Fayetteville, NC 
 (43.9 miles away)
910-615-3840
Experience:
18+ years
Languages Spoken:
English, Kannada, Polish, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jose Ruiz-Bonilla is a Hematologist Oncology specialist and a Hematologist practicing medicine in Fayetteville, North Carolina. He has been practicing medicine for over 18 years. Dr. Ruiz-Bonilla is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Angiosarcoma. Dr. Ruiz-Bonilla is currently accepting new patients.

Expertise in
44
conditions
Dr. Raghava R. Induru
Hematology | Oncology
Expertise in
44
conditions
Dr. Raghava R. Induru
Hematology | Oncology
Referral may be required
Before you request

Atrium Health Levine Cancer Institute, A Facility Of Carolinas Medical Center

945-B N. 5th St., 
Albemarle, NC 
 (58.3 miles away)
980-323-7790
Languages Spoken:
English, Hindi, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Raghava Induru is a Hematologist and an Oncologist practicing medicine in Albemarle, North Carolina. Dr. Induru is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Small Cell Lung Cancer (SCLC). Dr. Induru is board certified in American Board Of Family Medicine, Hospice And Palliative Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine, Medical Oncology. Dr. Induru is currently accepting new patients.

Expertise in
17
conditions
Dr. Madhu Chaudhry
Oncology | Hematology
Expertise in
17
conditions
Dr. Madhu Chaudhry
Oncology | Hematology
Referral may be required
Before you request

Scotland Cancer Treatment Center (Duke Cancer Network)

500 Lauchwood Dr, 
Laurinburg, NC 
 (0.1 miles away)
910-291-7630
Languages Spoken:
English, Hindi, Punjabi
See accepted insurances
Accepting New Patients
Offers Telehealth

My primary focus is to deliver high-quality and compassionate care to patients. I aim to treat all my patients like I would want my own family members to be treated. My grandmother died of gall bladder cancer. I accompanied her to all her appointments and that experience led me to choose the field of hematology-oncology. Trust between patients and their oncologists is paramount, and I strive to be my patients' trusted friend. Open discussion of all available treatment options and active participation of the patient is extremely important to me. Making patients aware of all evidence-based treatments and ongoing clinical trials before we create a mutually agreed upon treatment plan is crucial. I am always available to discuss various issues that may arise as part of a patient's treatment plan. Dr. Chaudhry is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Relapsed Refractory Multiple Myeloma (RRMM), and Multiple Myeloma. Dr. Chaudhry is board certified in American Board Of Internal Med, Medical Oncology , American Board Of Internal Med, Hematology, and American Board Of Internal Med, Internal Medicine . Dr. Chaudhry is currently accepting new patients.

Frequently Asked Questions about Dr. Sejal Dave

How do I make an appointment with Dr. Sejal Dave?

You can book an appointment with Dr. Sejal Dave by calling their office at 910-291-7630. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sejal Dave a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sejal Dave is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sejal Dave specialize in?

While Dr. Sejal Dave is a Hematology Oncology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Sejal Dave accept my insurance?

Dr. Sejal Dave accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 910-291-7630 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dave's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 80 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile